CoChat

Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000–2013

Open access
Vallabhaneni, Snigdha, Benedict, Kaitlin, Derado, Gordana, Mody, Rajal K. · 2017 · Open Forum Infectious Diseases

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.

Abstract

Background: Invasive aspergillosis (IA) and mucormycosis contribute to substantial mortality, especially among immunocompromised persons, including those with hematopoietic stem cell transplant (HSCT), hematologic malignancy (HM), and solid organ transplant (SOT). Methods: Using International Classification of Diseases, Ninth Revision codes available in the National Inpatient Sample, a hospital discharge database, we estimated IA-related hospitalizations (IA-RH), mucormycosis-RH (M-RH), HSCT-RH, HM-RH, and SOT-RH during 2000–2013. United States census data were used to calculate overall M-RH and IA-RH rates and present trends; estimated annual numbers of HSCT-RH, HM-RH, and SOT-RH served as denominators to calculate M-RH and IA-RH rates occurring with these conditions. Weighted least-squares technique was used to test for linear trends and calculate average annual percentage change (APC). Results: There were an estimated 169 110 IA-RH and 9966 M-RH during 2000–2013. Overall, IA-RH and M-RH rates per million persons rose from 32.8 to 46.0 (APC = +2.9; P < .001) and 1.7 to 3.4 (APC = +5.2%; P < .001), respectively, from 2000 to 2013. Among HSCT-RH, there was no significant change in M-RH rate, but a significant decline occurred in IA-RH rate (APC = −4.6%; P = .004). Among HM-RH, the rate of M-RH increased (APC = +7.0%; P < .001), but the IA-RH rate did not change significantly (APC = +1.2%; P = .073). Among SOT-RH, M-RH (APC = +6.3%; P = .038) and IA-RH rates (APC = +4.1%; P < .001) both increased. Conclusions: Overall IA-RH and M-RH rates increased during 2000–2013, with a doubling of M-RH. Mucormycosis-related hospitalization occurring in conjunction with certain comorbidities increased, whereas IA-RH rates among patients with the comorbidities, decreased, remained stable, or increased to a lesser extent than M-RH.

Overview

Integrity signals

Registry

Crossref · 10.1093/ofid/ofw268

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Research works printed but not linked: 1

  1. Park, 2011, Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006, Emerg Infect Dis, 17, 1855, 10.3201/eid1710.110087 · DOI · Paper page

Cited by

See all 103

Metadata

Authors
Vallabhaneni, S., Benedict, K., Derado, G., & Mody, R. K.
Affiliations
Centers for Disease Control and Prevention (US)
Venue
Open Forum Infectious Diseases
Published
2017-01-01
Volume
4
Issue
1
Pages
ofw268-ofw268
ISSN
2328-8957 (ISSN-L)
OpenAlex
W2577939788
Cited by
98
References
37
Citations by year
2026: 5 · 2025: 13 · 2024: 7 · 2023: 13 · 2022: 10 · 2021: 15 · 2020: 11 · 2019: 14 · 2018: 8 · 2017: 1
FWCI
7.16
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Open Forum Infectious Diseases (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Funders
Centers for Disease Control and Prevention
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
invasive aspergillosis, mucormycosis, hospitalization trends, hematopoietic stem cell transplantation, hematologic malignancies, solid organ transplantation, immunocompromised patients, fungal infection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.